Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients.

Publication ,  Journal Article
Liu, HC; Kreiner, D; Muasher, SJ; Jones, G; Jones, H; Rosenwaks, Z
Published in: Fertil Steril
July 1988

Serum human chorionic gonadotropin (hCG) was studied to test its predictability of pregnancy outcome in in vitro fertilization (IVF) patients. The mean +/- standard deviation of serum hCG concentration related to the day complete clearance of exogenous hCG was derived from 47 single term pregnancies as a normal range. This range can be used to predict spontaneous abortion (77%), multiple pregnancy (60%), and abortion in multiple-sac pregnancies terminating in the birth of fewer infants than the initial number of sacs (80%). The results also showed that our stimulation protocol did not affect the clearance rate and doubling time of endogenous hCG or implantation time as suggested by the time of endogenous hCG detection and that spontaneous abortion may be due to late implantation.

Duke Scholars

Published In

Fertil Steril

DOI

ISSN

0015-0282

Publication Date

July 1988

Volume

50

Issue

1

Start / End Page

89 / 94

Location

United States

Related Subject Headings

  • Pregnancy Outcome
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Humans
  • Fertilization in Vitro
  • Female
  • Embryo Transfer
  • Chorionic Gonadotropin
  • 3215 Reproductive medicine
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, H. C., Kreiner, D., Muasher, S. J., Jones, G., Jones, H., & Rosenwaks, Z. (1988). Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients. Fertil Steril, 50(1), 89–94. https://doi.org/10.1016/s0015-0282(16)60014-6
Liu, H. C., D. Kreiner, S. J. Muasher, G. Jones, H. Jones, and Z. Rosenwaks. “Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients.Fertil Steril 50, no. 1 (July 1988): 89–94. https://doi.org/10.1016/s0015-0282(16)60014-6.
Liu HC, Kreiner D, Muasher SJ, Jones G, Jones H, Rosenwaks Z. Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients. Fertil Steril. 1988 Jul;50(1):89–94.
Liu, H. C., et al. “Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients.Fertil Steril, vol. 50, no. 1, July 1988, pp. 89–94. Pubmed, doi:10.1016/s0015-0282(16)60014-6.
Liu HC, Kreiner D, Muasher SJ, Jones G, Jones H, Rosenwaks Z. Beta-human chorionic gonadotropin as a monitor of pregnancy outcome in in vitro fertilization-embryo transfer patients. Fertil Steril. 1988 Jul;50(1):89–94.
Journal cover image

Published In

Fertil Steril

DOI

ISSN

0015-0282

Publication Date

July 1988

Volume

50

Issue

1

Start / End Page

89 / 94

Location

United States

Related Subject Headings

  • Pregnancy Outcome
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Humans
  • Fertilization in Vitro
  • Female
  • Embryo Transfer
  • Chorionic Gonadotropin
  • 3215 Reproductive medicine
  • 1117 Public Health and Health Services